Literature DB >> 31373610

Psychiatric Practice Patterns and Barriers to the Adoption of Esketamine.

Samuel T Wilkinson1, David H Howard2, Susan H Busch3.   

Abstract

Entities:  

Year:  2019        PMID： 31373610     DOI： 10.1001/jama.2019.10728

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States.

Authors:  Eric L Ross; Djøra I Soeteman
Journal:  Psychiatr Serv       Date:  2020-07-07       Impact factor: 3.084

Review 2.  Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Authors:  Sandra J Drozdz; Akash Goel; Matthew W McGarr; Joel Katz; Paul Ritvo; Gabriella F Mattina; Venkat Bhat; Calvin Diep; Karim S Ladha
Journal:  J Pain Res       Date:  2022-06-15       Impact factor: 2.832

Review 3.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

Review 4.  Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements.

Authors:  Arif Khan; Kaysee Fahl Mar; Walter A Brown
Journal:  Psychopharmacol Bull       Date:  2021-06-01

5.  Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study.

Authors:  Sadia Shakeel; Shagufta Nesar; Hina Rehman; Khizra Jamil; Imran Ahsan Mallick; Muhammad Shahid Mustafa; Mudassir Anwar; Shazia Jamshed
Journal:  Pharmacy (Basel)       Date:  2021-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.